PAR 2.38% 20.5¢ paradigm biopharmaceuticals limited..

FiftyOne Capital, page-34

  1. 252 Posts.
    lightbulb Created with Sketch. 20
    hi oxxa ref mozzs post 42728928 today as an indicator. to go from 5-600 over 2-3 years to a starter of 10000 pa with longer term demand expected in the millions annually is the first flag. 51 cap dont support their assertion with hard numbers-hence a revisit by them with actual numbers would be welcome. second the volume of material delivered to patients via par injection system seems to be significantly greater than previous delivery methods hence more of the bene product needed for each treatment.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.